Ole Jannik Bjerrum
Professor, emeritus
Translational and Clinical Pharmacology
Jagtvej 160
2100 København Ø
- Published
A Paradigm Shift Towards Patient Involvement in Medicines Development and Regulatory Science: Workshop Proceedings and Commentary
Borup, G., Bach, K. F., Schmiegelow, M., Kildemoes, H. W., Bjerrum, Ole Jannik & Westergaard, N., May 2016, In: Therapeutic Innovation & Regulatory Science. 50, 3, p. 304-311 8 p.Research output: Contribution to journal › Comment/debate › Research › peer-review
- Published
A novel inhibitor of advanced glycation end- product formation inhibits mesenteric vascular hypertrophy in experimental diabetes
Bjerrum, Ole Jannik, 1999, In: Diabetologica. 42, p. 472-479 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
A simple method for the preparation and purification of C1 complement cleaved beta 2-microglobulin from human serum.
Nissen, Mogens Holst, Johansen, B. & Bjerrum, Ole Jannik, 1997, In: Journal of Immunological Methods. 205, 1, p. 29-33 4 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
An analysis of the fixed-dose combinations authorized by the European Union, 2009-14: A Focus on benefit-risk and clinial development condition
Sawicki-Wrzask, D., Thomsen, M. & Bjerrum, Ole Jannik, 2015, In: Therapeutic Innovation & Regulatory Science. 49, 4, p. 553-559 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Analysis of the Authorized Target Populations for Fixed Dose Combination Products Between 2000 and 2017 Reveals Discrepancies Between EMA's and FDA's Views on Initial Dual-Therapy
Bjerrum, Ole Jannik, Eichendorff, S. & Alkis, N. B., Mar 2020, In: Therapeutic Innovation & Regulatory Science. 54, 2, p. 297-302 6 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Analysis of the Authorized Target Populations for Fixed Dose Combination Products Between 2000 and 2017 Reveals Discrepancies Between EMA’s and FDA’s Views on Initial Dual-Therapy
Bjerrum, Ole Jannik, Eichendorff, S. & Alkis, N. B., 2019, In: Therapeutic Innovation & Regulatory Science. 6 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Body of evidence and approaches applied in the clinical development programme of fixed-dose combinations in the European Union from 2010 to 2016
Nøhr-Nielsen, A., De Bruin, M. L., Thomsen, M., Pipper, C. B., Lange, Theis, Bjerrum, Ole Jannik & Lund, Trine Meldgaard, 2019, In: British Journal of Clinical Pharmacology. 85, 8, p. 1829-1840 12 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Centrally mediated anti-noceptive action of GABAA receptor agonists in the spared nerve injury model of neuropathic pain
Bjerrum, Ole Jannik, 2005, In: European Journal of Pharmaceutical Sciences. 516, p. 131-138 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Co-administered gabapentin and venlafaxine in nerve injured rats: effect on mechanical hypersensitivity, motor function and pharmacokinetics
Folkesson, A. J. M., Honoré, P. G. H. & Bjerrum, Ole Jannik, 2009, In: Scandinavian Journal of Pain. 1, 2, p. 91-97Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Comparative pharmacokinetics between a microdose and therapeutic dose for clarithromycin, sumatriptan, propafenone, paracetamol (acetaminophen) and phenobarbital in human volunteers
Lappin, G., Shishikura, Y., Jochemsen, R., Weaver, R. J., Gesson, C., Houston, J. B., Oosterhuis, B., Bjerrum, Ole Jannik, Grynkiewicz, G., Alder, J., Rowland, M. & Garner, C., 20 Apr 2011, In: European Journal of Pharmaceutical Sciences. 43, 3, p. 141-150 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 1302721
Most downloads
-
2430
downloads
Genetik kan forudsige følsomhed for smerte
Research output: Contribution to journal › Journal article › Research
Published -
217
downloads
Pregabalin alleviates clinical signs of syringomyelia-related central neuropathic pain in Cavalier King Charles Spaniel dogs: a randomized controlled trial
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
28
downloads
Mechanical sensory threshold in Cavalier King Charles spaniels with syringomyelia-associated scratching and control dogs
Research output: Contribution to journal › Journal article › Research › peer-review
Published